Sandra Cauwenberghs

Sandra Cauwenberghs is a seasoned professional in the biotechnology and healthcare sectors, currently serving as Senior Director of Investor Relations at Galapagos since December 2020. Prior experience includes roles as a sell-side analyst at KBC Securities and various leadership positions in tumor biology and pharmacology at iTeos Therapeutics SA. Sandra's academic background features a Master of Business Administration from Vlerick Business School and extensive research credentials obtained during postdoctoral studies at RWTH Aachen University and KULeuven, culminating in a Master in Biochemistry. Additionally, Sandra holds certifications in company and product valuations in the pharma and biotech sectors, as well as a Certified European Financial Analyst designation.